肝星状细胞
肝纤维化
化学
脂质过氧化
GPX4
癌症研究
纤维化
四氯化碳
药理学
四氯化碳
谷胱甘肽
下调和上调
谷胱甘肽过氧化物酶
细胞生物学
氧化应激
肝细胞
生物化学
转化生长因子
去铁胺
肝损伤
细胞凋亡
活性氧
免疫学
生物
发病机制
泛素
细胞培养
自噬
作者
Laiyu Zhu,You Wu,Sainan Chang,Xinxin Ci
摘要
ABSTRACT Liver fibrosis is an increasingly serious global health issue, and an effective treatment strategy is to inhibit the activation of hepatic stellate cells (HSCs). The role of daphnetin (Daph), which is a natural coumarin derivative isolated from plants of the genus Daphne, in the treatment of hepatic fibrosis is still unclear. Mice were treated with carbon tetrachloride (CCl 4 ), and the inhibitory effect of Daph on hepatic fibrosis was evaluated. In vitro, the effect of Daph on the activated human HSCs line LX‐2 was studied. In vivo, Daph alleviated collagen accumulation and reduced the expression of fibrotic genes. However, these changes were reversed with ferrostatin‐1 (Fer‐1). In vitro, Daph induced ferroptosis in LX‐2 cells, which was characterized by increased lipid peroxidation and iron accumulation. However, deferoxamine (DFO) and Fer‐1 partially abrogated the antifibrotic effect of Daph. Mechanically, Daph exerted an antifibrotic effect by ubiquitinating glutathione peroxidase 4 (GPX4) and stimulating ferritinophagy‐mediated ferroptosis in HSCs. These results indicated that Daph promoted the ubiquitination of GPX4 and ferritinophagy‐mediated ferroptosis in HSCs, which could provide new clues for further pharmacological research on the antifibrotic effect of Daph.
科研通智能强力驱动
Strongly Powered by AbleSci AI